TELA Bio (TELA) Shares Outstanding (Diluted Average) (2019 - 2026)
TELA Bio's quarterly Shares Outstanding (Diluted Average) came in at $57.3 million in Q1 2026, up 26.49% year-on-year from $45.3 million in Q1 2025, and up 21.96% quarter-over-quarter from $46.9 million in Q4 2025.
TELA Bio has reported Shares Outstanding (Diluted Average) for 8 years, with the latest figure at $57.3 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 26.49% year-over-year to $57.3 million; the trailing twelve-month figure through Mar 2026 stood at $57.3 million (up 26.49% YoY), and the FY2025 full-year result was $46.9 million, up 64.58% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $57.3 million, up from $46.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $57.3 million in Q1 2026, with the low at $14.5 million in Q1 2022.
- Average Shares Outstanding (Diluted Average) over 5 years is $29.1 million, with a median of $24.6 million recorded in 2024.
- Year-over-year, Shares Outstanding (Diluted Average) gained 0.68% in 2024 and surged 84.27% in 2025.
- Tracing TELA's Shares Outstanding (Diluted Average) over 5 years: stood at $16.3 million in 2022, then soared by 40.58% to $22.9 million in 2023, then climbed by 24.74% to $28.5 million in 2024, then soared by 64.58% to $46.9 million in 2025, then climbed by 21.96% to $57.3 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $57.3 million (Q1 2026), $46.9 million (Q4 2025), and $45.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | 57.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.26 Mn |
| Dec 31, 2025 | 46.95 Mn |
| Sep 30, 2025 | 45.42 Mn |
| Jun 30, 2025 | 45.32 Mn |
| Mar 31, 2025 | 45.27 Mn |
| Dec 31, 2024 | 28.53 Mn |
| Sep 30, 2024 | 24.65 Mn |
| Jun 30, 2024 | 24.66 Mn |
| Mar 31, 2024 | 24.58 Mn |
| Dec 31, 2023 | 22.87 Mn |
| Sep 30, 2023 | 24.48 Mn |
| Jun 30, 2023 | 23.24 Mn |
| Mar 31, 2023 | 19.19 Mn |
| Dec 31, 2022 | 16.27 Mn |
| Sep 30, 2022 | 16.76 Mn |
| Jun 30, 2022 | 14.56 Mn |
| Mar 31, 2022 | 14.54 Mn |
| Dec 31, 2021 | 14.47 Mn |
| Sep 30, 2021 | 14.46 Mn |
| Jun 30, 2021 | 14.45 Mn |
| Mar 31, 2021 | 14.44 Mn |
| Dec 31, 2020 | 12.93 Mn |
| Dec 31, 2019 | 1.77 Mn |